Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis

Sobel, Jack D., Wiesenfeld, Harold C., Martens, Mark, Danna, Penny, Hooton, Thomas M., Rompalo, Anne, Sperling, Malcolm, Livengood, Charles +5 more·2004·New England Journal of Medicine

Cited by (489)

Items 201–300 of 489

  1. Assessment and management of vulval pain
    David Nunns, Ruth Murphy · 2012 · BMJ
  2. Hyaluronan in vaginal secretions: association with recurrent vulvovaginal candidiasis
    Ahinoam Lev‐Sagie, Paul Nyirjesy, Nicholas P. Tarangelo, Ann Marie Bongiovanni, Cynthia Bayer, Iara Moreno Linhares, Paulo César Giraldo, William J. Ledger, Steven Sol Witkin · 2009 · American Journal of Obstetrics and Gynecology
  3. Vaginale Candidose
    Herbert Hof · 2006 · Der Gynäkologe
  4. Miconazole-loaded nanoparticles coated with hyaluronic acid to treat vulvovaginal candidiasis
    Teixeira, Aniely Dos Reis, Quaresma, Amanda De Vasconcelos, Branquinho, Renata Tupinambá, Santos, Stephanie Lourrani Evangelista Neves, Magalhães, Juliana Teixeira De, Silva, Fábio Henrique Rodrigues Da, Marques, Maria Betânia De Freitas, Moura, Sandra Aparecida Lima De, Barboza, Ana Paula Moreira, Araújo, Marcelo Gonzaga De Freitas et al. · 2023 · European Journal of Pharmaceutical Sciences
  5. Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub‐analysis of the prospective multicentre phase IIb / III Prof‐001 study
    Andrea Lietz, Fanny Eckel, Herbert Kiss, M. Noe, Alex Farr · 2023 · Mycoses
  6. Recurrent Vulvo-Vaginal Candidiasis: Diagnostic and Management Challenges in a Developing Country Context
    Valentino Manase Lema · 2017 · Obstetrics & Gynecology International Journal
  7. Candidiasis, Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva
    Pedro Vieira‐Baptista, Jacob Bornstein · 2019 · Springer eBooks
  8. Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer
    Nikhil G. Rao, Gang Han, John Norman Greene, Tawee Tanvetyanon, Julie Ann Kish, Ronald C. De Conti, Michael David Chuong, Ravi Shridhar, Matthew C. Biagioli, Jimmy J. Caudell et al. · 2012 · Practical Radiation Oncology
  9. Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis—Results of a practitioner survey
    Cathy J. Watson, Marie V. Pirotta, Paulette Myers · 2012 · Complementary Therapies in Medicine
  10. Use of Dermasilk briefs in recurrent vulvovaginal candidosis: safety and effectiveness
    Antonietta D’Antuono, E. Baldi, Sara Bellavista, Nicoletta Banzola, Stefania Zauli, Annalisa Patrizi · 2011 · Mycoses
  11. Genital candidiasis
    Jack D. Sobel · 2005 · Medicine
  12. Vaginal mycobiome characteristics and therapeutic strategies in vulvovaginal candidiasis (VVC): differentiating pathogenic species and microecological features for stratified treatment
    Zimo Liu, Hua Yang, Roujie Huang, Xiaochuan Li, Tianshu Sun, Lan Zhu · 2025 · Clinical Microbiology Reviews
  13. A phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis
    Oluwatosin Goje, Nkechi E. Azie, David A Angulo, Ryan Sobel, Paul Nyirjesy, Jack D. Sobel · 2025 · American Journal of Obstetrics and Gynecology
  14. Recurrent Candida Vulvovaginitis
    Lauryn Nsenga, Felix Bongomin · 2022 · Venereology
  15. Fluconazole Prophylaxis in Prevention of Symptomatic Candida Vaginitis
    Kannika Story, Ryan Sobel · 2020 · Current Infectious Disease Reports
  16. Self-Sampling in the Diagnosis of Recurrent Vulvovaginal Candidosis
    Henke C. Vergers-Spooren, W I van der Meijden, Ad Luijendijk, Gilbert G.G. Donders · 2013 · Journal of Lower Genital Tract Disease
  17. Management of chronic vulvovaginal candidiasis: a long term retrospective study
    Yvonne Nguyen, Andrew Chak-Yiu Lee, Gayle O. Fischer · 2016 · Australasian Journal of Dermatology
  18. Vulvovaginitis and Cervicitis
    William M. McCormack · 2010 · Elsevier eBooks
  19. New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections
    Francesco De Seta, Adilia Warris, Elena Roselletti · 2025 · Frontiers in Microbiology
  20. Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America
    Peter G. Pappas, Carol A. Kauffman, David R. Andes, Daniel K. Benjamin, Thierry Calandra, John Ernest Edwards, Scott G. Filler, John F. Fisher, Bart Jan Kullberg, Luis L. Ostrosky-Zeichner et al. · 2009 · Clinical Infectious Diseases
  21. Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)
    Paul Vandecruys, Silke Baldewijns, Mart Sillen, Wouter Van Genechten, Patrick Van Dijck · 2023 · Expert Review of Anti-infective Therapy
  22. Single-dose Sertaconazole Vaginal Tablet Treatment of Vulvovaginal Candidiasis
    Peng‐Hui Wang, Hsiang‐Tai Chao, Cheng‐Li Chen, Chiou‐Chung Yuan · 2006 · Journal of the Chinese Medical Association
  23. Identification and Susceptibility Profile of Vaginal Candida Species to Antifungal Agents among Pregnant Women Attending the Antenatal Clinic of Thika District Hospital, Kenya
    Menza C. Nelson, Wanjiru Wanyoike, Muturi W. Margaret · 2013 · Open Journal of Medical Microbiology
  24. The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis
    Yuanting Tang, Yu Fan, Lairong Huang, Zhengqiang Hu · 2018 · Journal of Clinical Laboratory Analysis
  25. Vaginal Isolates of Candida glabrata Are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae
    Lance R. Fredericks, Mark D. Lee, Hannah R. Eckert, Shunji Li, Mason A. Shipley, Cooper R. Roslund, Dina A. Boikov, Emily A. Kizer, Jack D. Sobel, Paul Andrew Rowley · 2021 · Antimicrobial Agents and Chemotherapy
  26. Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis: A Drug Review
    Cameron Lanier, Tyler C. Melton · 2023 · Annals of Pharmacotherapy
  27. Inhibitory Effect of Eugenol and trans‐ Anethole Alone and in Combination with Antifungal Medicines on Candida albicans Clinical Isolates
    Marta Dąbrowska, Hanna Zielińska‐Bliźniewska, Pawel A. Kwiatkowski, Łukasz Łopusiewicz, Agata Pruss, Mateusz Kostek, Ewa Kochan, Monika Sienkiewicz · 2021 · Chemistry & Biodiversity
  28. Characteristics of the Skin Microbiome in Selected Dermatological Conditions: A Narrative Review
    Esther Olunoiki, Jacqueline Rehner, Markus Bischoff, Elena I. Koshel, THOMAS M. VOGT, Jörg Reichrath, Sören L. Becker · 2022 · Life
  29. Current Trends in Candidiasis
    Priya Uppuluri, Afshin Alaf Khan, John Ernest Edwards · 2017 · Springer eBooks
  30. La vulvovaginitis candidiásica recurrente
    Montserrat Cararach, Rafael Comino Delgado, Esteban Davi Armengol, Edda Marimon García, Juan Carlos Martínez Escoriza, Santiago Palacios, Josep M. Torres-Rodrı́guez · 2012 · Progresos de Obstetricia y Ginecología
  31. Increasing rate of non- Candida albicans yeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom
    Jennifer Ratner, Janet Wilson, Kevin Roberts, Catherine Armitage, Richard Barton · 2024 · Sexually Transmitted Infections
  32. Therapeutic Principles in Vulvovaginal Dermatology
    Jennifer R. Beecker · 2010 · Dermatologic Clinics
  33. A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro
    Maciej Masłyk, Monika Janeczko, Oleg M. Demchuk, Anna Boguszewska‐Czubara, Hieronim Golczyk, Anna Sierosławska, Anna Rymuszka, Aleksandra Martyna, Konrad Kubiński · 2017 · Saudi Pharmaceutical Journal
  34. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil
    L.D.S. Brandão, Douglas Boniek, Maria Aparecida de Resende, F.M.R. da Mata, Paulo Roberto Medeiros Azevedo, José Veríssimo Fernandes, Vânia Sousa Andrade · 2018 · Letters in Applied Microbiology
  35. Common vulval dermatoses.
    Catherine Drummond · 2011 · PubMed
  36. Vaginitis, Vulvitis, Cervicitis and Cutaneous Vulval Lesions
    Jack D. Sobel · 2016 · Elsevier eBooks
  37. Lab-Based Retrospective 10-Year Analysis Shows Seasonal Variation of Vaginal Candida Infection Rates in Belgium
    Gilbert G.G. Donders, Kateryna Ruban, Francesca Donders, Reinhilde Reybrouck · 2022 · Journal of Clinical Medicine
  38. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
    Juliana Lírio, Paulo César Giraldo, Ayane Cristine Alves Sarmento, Ana Paula Ferreira Costa, Ricardo Ney Cobucci, Humberto Saconato, José Eleutério, Ana Katherine Gonçalves · 2022 · Revista da Associação Médica Brasileira
  39. Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review
    Moira Bradfield Strydom, Sohil Ahmed Khan, Ramesh Lahiru Walpola, Robert Stuart Ware, Evelin Tiralongo · 2023 · Journal of Medical Microbiology
  40. Is mannose‐binding lectin serum concentration a reliable predictor for recurrent vulvovaginal candidiasis?
    Mona Ghazanfari, Mehraban Falahati, Azam Fattahi, Fatemeh Bazrafshan, Sanam Nami, Morteza Hosseinzadeh, Fariba Heydarikohan, Mohsen Ghelman, Majid Khoshmirsafa, Ali Farzanegan · 2017 · Mycoses
  41. Propolis Increases Neutrophils Response Against Candida Albicans through the Increase of Reactive Oxygen Species
    Nayara Cristina Alves de Lima, Bianca Altrão Ratti, Patricia Mendonca, Gilson Masahiro Murata, Raphaela Regina de Araújo Pereira, Celso Vataru Nakamura, Márcia Edilaine Lopes Consolaro, Terezinha Inez Estivalet Svidzinski, Elaine Hatanaka, Marcos Luciano Bruschi et al. · 2018 · Future Microbiology
  42. Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
    Robert A. Akins, Jack D. Sobel · 2009 · Humana Press eBooks
  43. Vaginal discharge
    Phillip Hay · 2018 · Medicine
  44. Stay It with Flora: Maintaining Vaginal Health as a Possible Avenue for Prevention of Human Immunodeficiency Virus Acquisition
    Lucy Y. Shin, Rupert Kaul · 2008 · The Journal of Infectious Diseases
  45. Practices of Lebanese gynecologists regarding treatment of recurrent vulvovaginal candidiasis
    Salim Adib, Elie Bared, Ramzi Fanous, Soula Kyriacos · 2011 · North American Journal of Medical Sciences
  46. Vaginal discharge: common causes and management
    Radhika McCathie · 2006 · Current Obstetrics and Gynaecology
  47. Prevention of invasiveCandidainfections in preterm infants: the time is now
    David A Kaufman · 2008 · Expert Review of Anti-infective Therapy
  48. Current Treatment Options for Vulvovaginal Candidiasis
    Jack D. Sobel · 2005 · Women s Health
  49. 2018 European IUSTI/WHO guideline on the management of vaginal discharge
    Jackie Sherrard, Janet Wilson, Gilbert G.G. Donders, Werner Mendling, Jørgen Skov Jensen · 2019 · Reproductive Endocrinology
  50. Maternal and Fetal Infections
    Patrick Duff, Richard L. Sweet, Rodney K. Edwards · 2009 · Elsevier eBooks
  51. Nifuratel-Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis
    Jael Apondi Obiero, Stephen Rulisa, Paul Ogongo, Charles Shey Wiysonge · 2018 · Cochrane Database of Systematic Reviews
  52. Candidoses et levuroses diverses
    M. Develoux, Stéphane Bretagne · 2005 · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses
  53. Infecciones cérvico vaginales y embarazo
    A. Marcelo Pradenas · 2014 · Revista Médica Clínica Las Condes
  54. NHG-Standaard Fluor vaginalis
    H J Dekker, P J A Boeke, A. J. Gercama, J G Kardolus, S F Boukes · 2009 · Bohn Stafleu van Loghum eBooks
  55. Difficult-to-Manage Vaginitis
    P. Janet Say, Cláudia Jacyntho · 2005 · Clinical Obstetrics & Gynecology
  56. Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro
    Luca Spaggiari, Andrea Ardizzoni, Natalia Pedretti, Ramona Iseppi, Carla Sabia, Rosario Russo, Samyr Kenno, Francesco De Seta, Eva Pericolini · 2024 · Microorganisms
  57. The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis
    Lanying Li, Xinyuan Zhang, Qian Li, Wen Zhong, Hua Zou · 2024 · Infection and Drug Resistance
  58. Non‐response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism
    Švitrigailė Grincevičienė, Gert Bellen, Kateryna Ruban, Gilbert G.G. Donders · 2017 · Mycoses
  59. Microbiome and Vulvovaginitis
    Anna Maya Powell, Isabella Sarria, Oluwatosin Goje · 2023 · Obstetrics and Gynecology Clinics of North America
  60. Features of vaginal bacteria community in women with recurrent vulvovaginal candidiasis
    Jian Shen, Shen, Min-jun, Su · 2015 · Chin J Reprod Contracep
  61. Recurrent vulvovaginal candidiasis.
    Mathieos Belayneh, Evan Sehn, Christina S. Korownyk · 2017 · Europe PMC (PubMed Central)
  62. Sexually transmitted diseases
    Anne Buvé, Marie Laga, Peter Piot · 1993 · Health Policy and Planning
  63. Perspectives on Vaginal Ecology and Management of Recurrent Vulvovaginal Candidiasis: A Narrative Review
    Danilla Grando, Cathy J. Watson · 2025 · Journal of Fungi
  64. Resistance to Antifungal Agents
    Beth A. Arthington, John H. Rex · 2007 · Springer eBooks
  65. Properties of Sustained-Release Single-Dose Formulations for Vulvovaginal Candidiasis
    Milan R. Henzl · 2005 · American Journal of Drug Delivery
  66. Évolution de la flore des levures isolées au CHU de Sfax, Tunisie
    F. Makni, Amira Sellami, H. Trabelsi, Hanen Sellami, F. Cheikhrouhou, S. Néji, Mohamed Ali Ayadi · 2010 · Journal de Mycologie Médicale
  67. Is multiple-site colonization with Candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent Candida vulvovaginitis?
    Gilbert G.G. Donders, Švitrigailė Grincevičienė, Gert Bellen, Kateryna Ruban · 2018 · Diagnostic Microbiology and Infectious Disease
  68. Mucosal Candidiasis
    Sanjay G. Revankar, Jack D. Sobel · 2014 · ASM Press eBooks
  69. Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
    Robert A. Akins, Jack D. Sobel · 2017 · Springer eBooks
  70. Microsatellite analysis of genotype distribution patterns of Candida albicans vulvovaginal candidiasis in Nanjing, China and its association with pregnancy, age and clinical presentation
    Caixia Li, Le Wang, Hua Tong, Yiping Ge, Huan Mei, Liangyu Chen, Guixia Lv, Weida Liu · 2016 · Archives of Gynecology and Obstetrics
  71. Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies
    Bárbara Gardella, Chiara Cassani, Mattia Dominoni, Marianna Francesca Pasquali, Arsenio Spinillo · 2024 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  72. New pharmacotherapeutic strategies for drug-resistant Candida infections: a review
    Jesse Raposa, José A. Vázquez · 2024 · Expert Opinion on Pharmacotherapy
  73. The human mycobiome: a critical yet understudied component of health and disease
    Rasoul Mohammadi, Hamid Morovati, Fatemeh Safari · 2025 · Microbiology
  74. Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis
    Carlo Genovese, Antonio Cianci, Salvatore Corsello, Giuseppe Ettore, Paolo Mattana, Gianna Tempera · 2019 · Minerva Obstetrics and Gynecology
  75. Candida albicans and Bacterial Vaginosis Can Coexist on Pap Smears
    Qingzhu Wei, Bo Fu, Jianghuan Liu, Zhixiong Zhang, Tong Zhao · 2012 · Acta Cytologica
  76. Infections of the Lower Genital Tract
    Linda O'Neal Eckert, Gretchen M. Lentz · 2007 · Elsevier eBooks
  77. RATIONAL FOR THE USE OF COCONUT OIL-BASED ANTI-MYCOTIC PESSARIES TO COMBAT RECURRENT VAGINAL INFECTION: IN VITRO/IN VIVO EVALUATION AND PRELIMINARY PROSPECTIVE CLINICAL INVESTIGATION
    Rabab Kamel, Haidy Abbas · 2018 · International Journal of Applied Pharmaceutics
  78. Genital candidiasis
    Jack D. Sobel · 2010 · Medicine
  79. Quantitative system for diagnosis of vulvovaginal candidiasis
    Dermendzhiev, T, Pehlivanov, B, Petrova, A, Stanev, S., Murdjeva, M. · 2022 · Journal of Medical Mycology
  80. Fruit Processing Byproducts as a Source of Natural Antifungal Compounds
    Gabriela Elena Viacava, María Roberta Ansorena, Sara I. Roura, Gustavo Adolfo González-Aguilar, Jesús Fernando Ayala-Zavala · 2013 · Springer eBooks
  81. Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
    Grant, Leah M., Orenstein, Robert · 2022 · Journal of Investigative Medicine High Impact Case Reports
  82. FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE.
    K M Khameneie, Nahid Arianpour, Rasool Roozegar, Majid Aklamli, M. Mohammadian Amiri · 2013 · PubMed
  83. Recurrent Vulvovaginal Infections: Etiology, Diagnosis, Treatment and Management
    Jatinder Singh, Namarta Kalia, Manpreet Kaur · 2018 · Springer eBooks
  84. Diagnosis and treatment of mucosa Candida spp. infections – a review article
    Marta Dąbrowska, Monika Sienkiewicz, Pawel A. Kwiatkowski, Michał Dąbrowski · 2019 · Annales Universitatis Mariae Curie-Sklodowska sectio C – Biologia
  85. Epidemiology and Prevention of Neonatal Candidiasis: Fluconazole for All Neonates?
    David A Kaufman · 2009 · Advances in experimental medicine and biology
  86. Protective effect of an oral natural phytonutrient in recurrent vulvovaginal candidiasis: a 12-month study.
    Arti Kumari, M P Bishier, Yuji Naito, Ambudhar Sharma, Umberto Solimene, S Jain, Hariom Yadav, Emilio Minelli, Claudio Tomella, Francesco Marotta · 2011 · PubMed
  87. Vulvovaginitis and Cervicitis
    William M. McCormack, Michael H. Augenbraun · 2015 · Elsevier eBooks
  88. The interaction between HIV and other sexually transmitted infections in South Africa: a model-based evaluation
    Leigh Francis Johnson · 2008 · Open University of Cape Town (University of Cape Town)
  89. Diagnosis and management of yellow nail syndrome: An international multi-institutional retrospective cohort study of 111 cases by an expert panel
    Kaya L. Curtis, Bianca Maria Piraccini, Michela Valeria Rita Starace, Luca Rapparini, Bertrand Richert, Adam Ian Rubin, Nathaniel J. Jellinek, Antonellá Tosti, Nilton Gióia Di Chiacchio, Nilton Gioia Di Chiacchio et al. · 2025 · Journal of the American Academy of Dermatology
  90. A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo
    Irene Paterniti, Giovanna Casili, Alessia Filippone, Marika Lanza, Alessio Ardizzone, Anna Paola Capra, Michela Campolo, Emanuela Esposito · 2022 · Journal of Fungi
  91. Treatment for recurrent vulvovaginal candidiasis (thrush)
    Cooke, Georga, Watson, Cathy, Smith, Jane, Pirotta, Marie, van Driel, Mieke L · 2011 · Cochrane Database of Systematic Reviews
  92. Candida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance
    Michael D. LaFleur · 2011 · The Open Mycology Journal
  93. Prophylactic strategies in recurrent vulvovaginal candidiasis: a 2-year study testing a phytonutrient vs itraconazole.
    Chopra, Francesco Marotta, Arti Kumari, M P Bishier, F He, Nicola Zerbinati, Chandra Shekhar Agarwal, Y Naito, Claudio Tomella, Ambudhar Sharma et al. · 2013 · PubMed
  94. Vulvovaginite : Dépistage et prise en charge de la trichomonase, de la candidose vulvovaginale et de la vaginose bactérienne
    Julie van Schalkwyk, Mark Harris Yudin · 2016 · Journal of Obstetrics and Gynaecology Canada
  95. Elevated nitric oxide in recurrent vulvovaginal candidiasis – association with clinical findings
    Cathrin Alvendal, Sophia Ehrström, Annelie Brauner, Jon O. Lundberg, Nina Bohm‐Starke · 2017 · Acta Obstetricia Et Gynecologica Scandinavica
  96. CHANGING TRENDS OF CANDIDA ISOLATES AND THEIR ANTIFUNGAL SUSCEPTIBILITY PATTERN IN VULVOVAGINAL CANDIDIASIS CASES OF TRIPURA, NORTH EAST INDIA
    Jhinuk Basu Mullick, Tapan Majumdar, Jayanta Ray, Samir Kumar Sil · 2015 · Journal of Evolution of Medical and Dental Sciences
  97. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2017 · Springer eBooks
  98. Guía de práctica clínica para el manejo sindrómico de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital - 2013
    Hernando Gaitán‐Duarte, Andrea Esperanza Rodriguez-Hernandez, Ingrid Arévalo-Rodríguez, Edith Ángel‐Müller, Hugo López‐Ramos, Jesús Santiago Estrada-Mesa, Colaboradores Grupo Desarrollador de la De manejo sindrómico ITS y otras ITG · 2013 · Revista Colombiana de Obstetricia y Ginecología
  99. PREVALENCE AND PRODUCTION OF ENZYMES BY Candida ISOLATES FROM VAGINAL SECRETION SAMPLES
    Suzane Katy Rocha Oliveira, Dália Cristine Vaz dos Anjos, Luís Henrique Bastos Gonçalves, Thiago Azevedo Feitosa Ferro, Sílvio Gomes Monteiro, Patrícia de Maria Silva Figueirêdo, Cristina de Andrade Monteiro · 2013 · Revista de Patologia Tropical / Journal of Tropical Pathology
  100. Vulvar vestibulitis: Pathophysiology and management
    Alessandra Graziottin, Niccolò Giovannini, Laura Bertolasi, Mara Bottanelli · 2004 · Current Sexual Health Reports